Skip to main content
European Commission logo
Enterprise Europe Network

Edible internal teat sealant for animal udders developed by Greek researchers

Summary

Profile Type
Technology offer
POD Reference
TOGR20240315011
Term of Validity
15 March 2024 - 15 March 2025
Company's Country
Greece
Type of partnership
Investment agreementResearch and development cooperation agreement
Targeted Countries
All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A Greek research team has created a patented heavy metal-free formulation to seal dairy animal udders without the need for removal prior to milking or calving. It is looking for partnerships with large organisations that have research capabilities in order to further develop its technology and prepare it for product commercialisation.
Full Description
This project is a joint effort between three research laboratories at one of the oldest universities in Greece, established almost a century ago. The research team is made up of experts in the fields of animal husbandry, veterinary medicine, and pharmaceutical technology, and their aim was to design and develop an innovative formulation specifically related to the udder health of dairy animals.

Udder health is a key issue, and is directly linked to the productivity and longevity of dairy animals, as well as the financial viability of farms. Intramammary infections are caused by pathogens entering through the teat canal, and their prevention of is a major priority for dairy farmers. Up until now, this has been achieved by using internal teat sealants at the commencement of the drying-off period, in other words, when milking is stopped for a certain period (usually 60 days) before the next calving. Commercial products that are currently available are mainly composed of paraffin and a heavy metal named bismuth subnitrate, therefore they need to be thoroughly removed from the teat canal in order to avoid any toxic substances getting into the milk. This can only be done by stripping them out manually and discarding the milk of three continuous milking cycles.

The Greek technology on offer is a European patented formulation based on structured vegetable oils. It is bismuth and paraffin free. The Greek team have conducted scientific studies on the cytocompatibility of the formulation (in other words the property of not being harmful to a cell). This research has shown that owing to its composition, the substance is completely bioinert and non-toxic, thus it does not require removal. These findings are also supported by a clinical trial performed on dairy sheep by the Greek team. The clinical trial data highlight the safety, biocompatibility, and overall performance of the technology.

The client is looking for partnerships with large organisations that have research capabilities in order to further develop its technology and prepare it for product commercialisation. The team is also interested in discussing possible collaboration with potential investors.
Advantages and Innovations
Owing to its edible composition, the proposed teat sealant does not need to be removed before milking. Thus, it has a clear competitive advantage over existing products, which must be stripped out manually, followed by discarding the milk of three continuous milking cycles. This feature has a tremendously positive economic effect on the milk production industry, as it offers fast milk production, no waste, and the possibility of accessing potentially valuable by-products like colostrum, which is the first milk produced during pregnancy, that would otherwise have to be dumped. Therefore, the unique properties of this formula can help to minimise the industry's environmental footprint.

Moreover, the Greek team is making significant strides towards the prevention and management of intramammary infections, as well as the development of additional features such as use of the formula for intramammary drug delivery in order to provide immediate and/or sustained release of veterinary pharmaceutical preparations.
Stage of Development
Available for demonstration
Sustainable Development Goals
Goal 12: Responsible Consumption and ProductionGoal 3: Good Health and Well-beingGoal 15: Life on LandGoal 9: Industry, Innovation and Infrastructure

Partner Sought

Expected Role of a Partner
The client seeks partnerships with large organisations that have research capabilities in order to further develop its technology and prepare it for product commercialisation.

Additionally, the Greek team is interested in identifying potential investors who would be willing to offer financial support for the technology’s development.
Type and Size of Partner
Big companySME 50 - 249
Type of partnership
Investment agreementResearch and development cooperation agreement

Call details

Coordinator required
Yes

Dissemination

Technology keywords
07001002 - Animal Production / Husbandry07001009 - Veterinary Medicine
Market keywords
05009003 - Animal health09005 - Agriculture, Forestry, Fishing, Animal Husbandry & Related Products
Sector Groups Involved
Agri-FoodHealth
Targeted countries
All countries

Images